ArticleCell reports. Medicine2026

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.

Elena Adan-Villaescusa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.